NEWS ON THE FIGHT TO END HIV/AIDS, VIRAL HEPATITIS, AND TUBERCULOSIS
Lost in Translation
We’re thrilled to share the 2023 edition of TAGline, which explores some of the barriers that obstruct research from being effectively implemented to improve people’s health. Since TAG’s founding three decades ago, scientific research has produced more than a few potentially game-changing advancements – under optimal conditions, HIV is manageable and preventable, tuberculosis (TB) is preventable and curable with fewer side-effects than ever before, and hepatitis C Virus (HCV) is curable. And yet, as TAG supporters and allies well know, these developments have still yet to benefit everyone who needs them. Taking whatever action possible to ensure these breakthroughs don’t get “lost in translation” from labs to lives has always been at the heart of our work.
These articles aim to unpack what’s hindering the best possible application of science in the fight against HIV, TB, and HCV. Such challenges include lack of community awareness and political will, rising bigotry targeting queer communities, inadequate preparedness for new product rollouts, inappropriate country-level treatment guidelines and more. We believe that community-based civil society has a key role to play in addressing these ongoing issues, to extend the benefits of scientific research to everyone, everywhere.
Thank you, as always, for your support. We hope you enjoy this issue of TAGline.
In this issue of TAGline:
Translating Scientific Research from Labs to Lives
By Natalie Shure
Are We There Yet? TB Preventive Treatment Beyond TB/HIV Integration
By Lynette Mabote-Eyde and Mike Frick
How Rising Anti-LGBTQ Sentiment Harms Public Health
By Kendall Martinez-Wright, Elizabeth Lovinger, and De'Ashia Lee
Misinformation and Vaccine Preparedness: The Case for Digital Advocacy
By Erin McConnell
Beyond Intellectual Property: Why Is Generic Treatment for HCV Still So Hard to Get
By Joelle Dountio Ofimboudem and Sara Helena Gaspar